The global Myopia and Presbyopia Treatment market was valued at around US$ 16.7 Bn in 2021. With a projected CAGR of 9.5% for the next ten years, the market is likely to reach a valuation of nearly US$ 45 Bn by the end of 2032.
Transparency Market Research reveals that corrective lenses is the top myopia treatment type. Revenue through corrective lenses grew at 10.3% during 2017-2021 and is expected to grow at a rate of 11% during the forecasted period set between 2022 and 2032.
|
Attributes |
Details |
|
Myopia and Presbyopia Treatment Market Size (2021A) |
US$ 16.7 Bn |
|
Myopia and Presbyopia Treatment Market Size (2022E) |
US$ 18.2 Bn |
|
Myopia and Presbyopia Treatment Projected Market Value (2032F) |
US$ 45 Bn |
|
Global Myopia and Presbyopia Treatment Market Growth Rate (2022-2032) |
9.5% CAGR |
|
United States Myopia and Presbyopia Treatment Growth Rate (2022-2032) |
~10% CAGR |
|
Key Countries Profiled |
|
Globally, more than 2 billion people suffer from vision impairment. Short and far sightedness, glaucoma and cataracts have been common in at least 1 billion people, according to the reports of World Health Organization (WHO). Moreover, as life span has increased over the past 50 years, there is a rise in older population and is set to double in next 20 years. With an ageing population, vision loss and blindness shoots up. The number of older population in the U.S. is projected to more than double and reach 90 Million by 2050. This will drive the demand for presbyopia treatments among adults. Besides, around 1.1 Bn people in 2020, had farsightedness or untreated presbyopia. Therefore, the demand for myopia and presbyopia treatment is likely to increase exponentially as population grows older.
WHO accounts for poor vision as one of the key causes of disability globally. Eye problems tend to be more common in rural area, notably people from low income groups, women and geriatric population and ethnic minorities. This depicts that substantial portion of the global population need eye care and other services.
Generally, people do not prefer to get their eyes treated which acts as a biggest obstacle against the market for myopia and presbyopia treatment. The perception among public for health issues only lies in cancer and cardiac issues. The common cause attributing to this is lack of awareness among people. Even when services are made available to the rural public, they are less likely to approach it due to numerous misconceptions. Nearly 59% of older population in India believe that cataract can be averted on its own.
A survey entitled as ‘More to see’ states that 80% of blindness can be avoided only if people acknowledge the idea of getting treated. Around 42% of population are not familiar with eye-related issues. With more than 80% of unaddressed near-sightedness conditions are prevalent in western, eastern and central sub-Saharan Africa while untreated distant vision conditions are about four times higher in low and middle income regions when compared to high income regions. Moreover, as the incidents of presbyopia is rising, there is a vital need among senior citizens to be made aware about the corrective measures and false beliefs regarding eye treatment.
Furthermore, if the vision is not treated at a proper time it could cost global financial burden. According to WHO, vision impairment from untreated myopia and presbyopia only can cost US$ 244 Bn and US$ 25.4 Bn respectively from productivity losses.
With growing developments and rise in FDA approval to new drugs, the focus has shifted to preservation of vision and creation of a wide range of possibilities for improved vision and eye care. People now receive better eye care services with advanced equipment and sophisticated tools engineered to save time on half of the treatments.
For instance, adoption of advanced phacoemulsification systems offers a variety of ranges for intraocular lens. Also, with the advent of the Femtosecond laser, cataract surgery for presbyopia patients has become extremely safe and less tissues are affected around the eyes.
Even techniques based on contact lens have emerged which can record eye pressure for the whole day and give hints to therapeutic efficacy, thereby giving an idea about the type of glaucoma present in the person.
Future in myopia and presbyopia treatment lies in advancements under stem cell therapy, gene therapy and innovations in the approach of implanting sensors in the eye.
Diabetes can impact various parts of the eye. Diabetes may influence the early development of far-sightedness, near-sightedness, and presbyopia. Primarily known as diabetic retinopathy, is a condition that causes vision loss and ultimately leads to blindness among diabetic patients. The blood vessels of the retina get affected in this process. Diabetic retinopathy also doubles the rate of getting other eye-related problems such as cataract and open-angle glaucoma.
According to the Centers for Disease Control and Prevention (CDC), 12,000 to 24,000 cases of blindness are rising from diabetes in the U.S. alone. Half of the patients with type 1 and type 2 diabetes develop retinopathy within first two decades of developing diabetes. Blindness developing from diabetes, pose a significant burden and costs the US healthcare system US$500 Mn every year.
North America dominates the market for myopia and presbyopia treatment and achieved a growth rate of 10.3% in 2017-2021. The market in North America is expected to achieve 9.7% CAGR during the forecasted period of 2022-2032. Based on U.S. Census Bureau report, amount of presbyopia patients is likely to reach 123 Mn in 2020. Moreover, Presbyopia is a common condition affecting 128 Mn Americans. Growth in the market can be attributed to high number of myopia and presbyopia patients, increased adoption of contact lenses, surgery. Furthermore, innovations in eye care technology is increasing awareness among patients, which is fuelling growth in North America.
The myopia prevalence rate in the U.S. stands at 23.9%, while the prevalence is in over 34 Mn population. Idaho, Utah, Minnesota, Indiana, Vermont, and Maine are the U.S. states where myopia is most prevalent. With these statistics, the market for myopia and presbyopia treatment in the U.S. is projected to reach a valuation of US$ 17 Bn, growing at a CAGR of 10%.
The overall frequency of primary myopia in the UK population stands at 26.9%, comprising 4.0% high myopia, 9.5% moderate myopia, and 13.3% low myopia. Besides, nearly one in five teenagers in the UK are myopic. As compared to that in 1960s, myopia has increased to more than twice among the UK children. With these statistics, the market for myopia and presbyopia treatment in the U.K. is projected to reach a valuation of US$ 1.6 Bn, growing at a CAGR of 7.3% during 2022 – 2032.
With a high geriatric population, Japan has significant number of people suffering from myopia and presbyopia disorders. Other than that, in Japan, almost 19 out of 20 teenagers are shortsighted. 76.5 percent of the young adults aged six to 11 and nearly 94.9 percent of the youngsters aged 12 to 14 were myopic. The prevalence of myopia with an axial length of 26mm or greater was 15.2 percent among the older age group. The market for myopia and presbyopia in Japan is projected to reach a valuation of US$ 1.5 Bn by 2032.
China witnessed a significant rise in myopia and presbyopia treatment. Its market is valued at US$ 5.4 Bn in 2032. The expected growth rate of the market in China for myopia and presbyopia treatment was estimated at 10.3% during 2017-2021. It is set to witness 12.2% CAGR during the forecast period. In rural China, half of the population is affected with presbyopia and has no access to correction. Moreover, China contributes to substantial portion of myopic population in Asia-Pacific and contributes to early myopia epidemic. According to National Health Commission (NHC) almost 52.7% of Chinese children and teenagers suffer from myopia in 2020 and myopia rate for students in primary, middle and high school stood at 35.6%, 71.1% and 80.5% respectively. China has taken several initiatives in combatting myopia epidemic. For instance, a leading Chinese ophthalmology, Aier Eye Hospital, initiated one stop personalized diagnosis and treatment model to prevent and limit myopia among children. NHC aims to improve the rate of eye care and vision testing services by the end of 2025 for children below 6. With these statistics, it will be no wonder to expect China as a market with a US$ 3.7 Bn absolute dollar opportunity between 2022 and 2032.
Why people are preferring corrective type method to improve their vision and how is it impacting the myopia and presbyopia treatment?
There has been a rise in corrective type vision improvement method among the population which is expected to see a growth rate of 11% during the forecast period. Many individuals opt for vision correction through glasses and contact lenses while few intend on going for surgery. According to Vision Council data, 76% of the U.S. population prefer to use different ways of vision correction. That is most patients opt for glasses or contact lenses.
People usually do not opt for other vision correction methods like surgery or through special drugs due to its related side effects and therefore prefer wearing glasses or contacts. Moreover, FDA has not approved LASIK surgery options for children aged below 18. Therefore, the demand for Vision Correction through contact lenses and glasses is here to stay in coming years.
At present, eye care industry is focussing on research and development, getting FDA approvals and expanding eye care technology. The key companies operating in the Myopia and Presbyopia Treatment market are Ziemer Ophthalmic Systems AG, NIDEK CO., LTD., Johnson & Johnson Vision, Essilor Ltd., Zeiss International, ALCON VISION LLC, Bausch & Lomb Incorporated, Carl Zeiss AG, Orasis Pharmaceuticals,Regeneron Pharmaceuticals Inc., Haag-Streit UK, Topcon Corporation, AbbVie, Sydnexis and The Cooper Companies Inc.
Some of the recent developments by key providers of Myopia and Presbyopia Treatment are as follows:
Similarly, recent developments related to companies offering Myopia and Presbyopia Treatment have been tracked by the team at Transparency Market Research, which is available in the full report.
Myopia and Presbyopia Treatment Market by Type:
Myopia and Presbyopia Treatment Market by Region:
The global Myopia and Presbyopia Treatment market was valued at US$ 16.7 Bn in 2021 and achieved a growth rate of 8.3% during 2017 and 2021.
The Myopia and Presbyopia Treatment industry is set to witness a high growth rate of 9.5% over the forecast period and be valued at US$ 45 Bn by 2032.
Ziemer Ophthalmic Systems AG, Johnson & Johnson Vision, Zeiss, Bausch & Lomb Inc., Topcon Corporation are the key providers of Myopia and Presbyopia Treatment.
The vision correction method through Prescription, Contact and Intraocular lenses is driving market demand.
U.S., U.K., China, Japan and South Korea are expected to drive the most sales growth of Myopia and Presbyopia Treatment.
North America is expected to dominate the market by 8.6% CAGR during 2017-2021 and is expected to grow at a rate of 9.7% during the forecasted period.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Myopia Treatment Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Myopia Treatment Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Myopia Treatment Type, 2022-2032
5.3.1. Corrective
5.3.1.1. Prescription Lenses
5.3.1.2. Contact Lenses
5.3.1.3. Intraocular Lenses
5.3.2. Surgical
5.3.3. Drugs
5.4. Y-o-Y Growth Trend Analysis By Myopia Treatment Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Myopia Treatment Type, 2022-2032
6. Global Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Myopia Treatment Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Myopia Treatment Type
7.4. Key Takeaways
8. Latin America Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Myopia Treatment Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Myopia Treatment Type
8.4. Key Takeaways
9. Europe Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. U.K.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Myopia Treatment Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Myopia Treatment Type
9.4. Key Takeaways
10. Asia Pacific Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Myopia Treatment Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Myopia Treatment Type
10.4. Key Takeaways
11. Middle East and Africa Myopia and Presbyopia Treatment Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Myopia Treatment Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Myopia Treatment Type
11.4. Key Takeaways
12. Key Countries Myopia and Presbyopia Treatment Market Analysis
12.1. U.S.
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2021
12.1.2.1. By Myopia Treatment Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2021
12.2.2.1. By Myopia Treatment Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2021
12.3.2.1. By Myopia Treatment Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2021
12.4.2.1. By Myopia Treatment Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2021
12.5.2.1. By Myopia Treatment Type
12.6. U.K.
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2021
12.6.2.1. By Myopia Treatment Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2021
12.7.2.1. By Myopia Treatment Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2021
12.8.2.1. By Myopia Treatment Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2021
12.9.2.1. By Myopia Treatment Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2021
12.10.2.1. By Myopia Treatment Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2021
12.11.2.1. By Myopia Treatment Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2021
12.12.2.1. By Myopia Treatment Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2021
12.13.2.1. By Myopia Treatment Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2021
12.14.2.1. By Myopia Treatment Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2021
12.15.2.1. By Myopia Treatment Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2021
12.16.2.1. By Myopia Treatment Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2021
12.17.2.1. By Myopia Treatment Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2021
12.18.2.1. By Myopia Treatment Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2021
12.19.2.1. By Myopia Treatment Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Myopia Treatment Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Ziemer Ophthalmic Systems AG
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. NIDEK CO., LTD.
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Johnson & Johnson Vision
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Essilor Ltd.
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Zeiss International
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. ALCON VISION LLC
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. Bausch & Lomb Incorporated.
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Carl Zeiss AG
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Orasis Pharmaceuticals
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Regeneron Pharmaceuticals Inc.
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
14.1.11. Haag-Streit UK
14.1.11.1. Overview
14.1.11.2. Product Portfolio
14.1.11.3. Profitability by Market Segments
14.1.11.4. Sales Footprint
14.1.11.5. Strategy Overview
14.1.11.5.1. Marketing Strategy
14.1.12. Topcon Corporation
14.1.12.1. Overview
14.1.12.2. Product Portfolio
14.1.12.3. Profitability by Market Segments
14.1.12.4. Sales Footprint
14.1.12.5. Strategy Overview
14.1.12.5.1. Marketing Strategy
14.1.13. AbbVie
14.1.13.1. Overview
14.1.13.2. Product Portfolio
14.1.13.3. Profitability by Market Segments
14.1.13.4. Sales Footprint
14.1.13.5. Strategy Overview
14.1.13.5.1. Marketing Strategy
14.1.14. Sydnexis
14.1.14.1. Overview
14.1.14.2. Product Portfolio
14.1.14.3. Profitability by Market Segments
14.1.14.4. Sales Footprint
14.1.14.5. Strategy Overview
14.1.14.5.1. Marketing Strategy
14.1.15. The Cooper Companies Inc
14.1.15.1. Overview
14.1.15.2. Product Portfolio
14.1.15.3. Profitability by Market Segments
14.1.15.4. Sales Footprint
14.1.15.5. Strategy Overview
14.1.15.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
List of Tables
Table 1: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Region, 2017-2032
Table 2: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
Table 3: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 4: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
Table 5: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 6: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
Table 7: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 8: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
Table 9: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 10: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
Table 11: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Country, 2017-2032
Table 12: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) Forecast by Myopia Treatment Type, 2017-2032
List of Figures
Figure 1: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
Figure 2: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) by Region, 2022-2032
Figure 3: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Region, 2017-2032
Figure 4: Global Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Region, 2022-2032
Figure 5: Global Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Region, 2022-2032
Figure 6: Global Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
Figure 7: Global Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
Figure 8: Global Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
Figure 9: Global Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
Figure 10: Global Myopia and Presbyopia Treatment Market Attractiveness by Region, 2022-2032
Figure 11: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
Figure 12: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 13: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 14: North America Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 15: North America Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 16: North America Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
Figure 17: North America Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
Figure 18: North America Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
Figure 19: North America Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
Figure 20: North America Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
Figure 21: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
Figure 22: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 23: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 24: Latin America Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 25: Latin America Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 26: Latin America Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
Figure 27: Latin America Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
Figure 28: Latin America Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
Figure 29: Latin America Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
Figure 30: Latin America Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
Figure 31: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
Figure 32: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 33: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 34: Europe Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 35: Europe Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 36: Europe Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
Figure 37: Europe Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
Figure 38: Europe Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
Figure 39: Europe Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
Figure 40: Europe Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
Figure 41: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
Figure 42: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 43: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 44: Asia Pacific Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 45: Asia Pacific Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 46: Asia Pacific Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
Figure 47: Asia Pacific Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
Figure 48: Asia Pacific Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
Figure 49: Asia Pacific Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
Figure 50: Asia Pacific Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
Figure 51: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) by Myopia Treatment Type, 2022-2032
Figure 52: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) by Country, 2022-2032
Figure 53: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Country, 2017-2032
Figure 54: Middle East and Africa Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Country, 2022-2032
Figure 55: Middle East and Africa Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Country, 2022-2032
Figure 56: Middle East and Africa Myopia and Presbyopia Treatment Market Value (US$ Mn) Analysis by Myopia Treatment Type, 2017-2032
Figure 57: Middle East and Africa Myopia and Presbyopia Treatment Market Value Share (%) and BPS Analysis by Myopia Treatment Type, 2022-2032
Figure 58: Middle East and Africa Myopia and Presbyopia Treatment Market Y-o-Y Growth (%) Projections by Myopia Treatment Type, 2022-2032
Figure 59: Middle East and Africa Myopia and Presbyopia Treatment Market Attractiveness by Myopia Treatment Type, 2022-2032
Figure 60: Middle East and Africa Myopia and Presbyopia Treatment Market Attractiveness by Country, 2022-2032
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Myopia and Presbyopia Treatment Market
